Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoosier Cancer Research Network
With
Purdue University
Indiana University
OUTLINE: This is a multi-center study.
The treatment plan for each breast cancer subject will be determined at the discretion of the treating physician and subject. This protocol does not prescribe any particular standard of care treatment.
There will be no treatment for the healthy volunteers.
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
FOR WOMEN WITH BREAST CANCER
Histologically or cytologically confirmed invasive malignancy or ductal carcinoma in situ of the breast.
Preparing to begin a new regimen for breast cancer (adjuvant, locally recurrent, any line metastatic).
Female.
Age \> 18 years at the time of consent.
Written informed consent and HIPAA authorization for release of personal health information.
FOR HEALTHY VOLUNTEERS
No known history of invasive malignancy or ductal carcinoma in situ. Volunteers must not have prior history of malignancy in the past 5 years with the exception of basal cell and squamous cell carcinoma of the skin. Other cancers with low potential for metastasis, such as in situ cancers (e.g., Grade 1, TA TCC (low grade superficial bladder cancer), colonic polyp with focus of adenocarcinoma) can also be enrolled as healthy volunteers.
Female
Age \> 18 years at the time of consent.
Written informed consent and HIPAA authorization for release of personal health information.
You may not be if
Females must not be pregnant.
Clareo Health | A Biological Sample Collection Protocol of Women With and Without Breast Cancer
